Search

Product Description

    News: 2024.03.21

    JD Health’s full-year net profit rises 4.6 times

    JD Health (6618) announced that as of the end of last year, its full-year net profit was 2.142 billion yuan (RMB, the same below), up 4.6 times year-on-year, with earnings per share of 0.69 yuan, and no final dividend was paid. Last year’s non-IFRS…

    JD Health’s full-year net profit rises 4.6 times

    JD Health announced in its latest financial report that as of the end of last year, the company's full-year net profit reached 2.142 billion yuan, an increase of 4.6 times compared with the same period last year. This astonishing growth figure surprised investors and demonstrated the strong performance of the company's business operations.

    Earnings per share reached 0.69 yuan

    In addition to the substantial growth in net profit for the year, JD Health's earnings per share also reached 0.69 yuan, which means that the company's profitability per share in the past year was considerable. Investors are confident in the company's future development prospects.

    No final dividend will be paid

    It is worth noting that JD Health announced in its financial report that it will not pay final dividends, which may be to retain more funds for future business expansion and investment. This move shows that the company has clear plans and strategies for future development.

    • JD Health’s non-IFRS last year
    • The company has achieved significant performance growth over the past year
    • Investors are confident in the company's future development prospects

    Overall, JD Health has achieved impressive performance over the past year, with the company's full-year net profit increasing significantly and earnings per share reaching a record high. Investors are confident in the company's future development and believe that JD Health will continue to maintain strong business growth in the future.